BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1622 related articles for article (PubMed ID: 27503326)

  • 1. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
    Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
    Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
    Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
    Storck SE; Meister S; Nahrath J; Meißner JN; Schubert N; Di Spiezio A; Baches S; Vandenbroucke RE; Bouter Y; Prikulis I; Korth C; Weggen S; Heimann A; Schwaninger M; Bayer TA; Pietrzik CU
    J Clin Invest; 2016 Jan; 126(1):123-36. PubMed ID: 26619118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M; Silva SC; Santana I; Cardoso I
    CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
    Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
    J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
    P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
    Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
    Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
    Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice.
    Tian T; Bai D; Li W; Huang GW; Liu H
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
    Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
    Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
    Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.